Cargando…
The p53 inducing drug dosage may determine quiescence or senescence
Autores principales: | Lane, David P., Verma, Chandra, Fang, Cheok Chit |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006013/ https://www.ncbi.nlm.nih.gov/pubmed/21068468 |
Ejemplares similares
-
mTOR favors senescence over quiescence in p53-arrested cells
por: Schug, Thaddeus T.
Publicado: (2010) -
Another "Janus paradox" of p53: induction of cell senescence versus quiescence
por: Darzynkiewicz, Zbigniew
Publicado: (2010) -
Drugging in the absence of p53
por: Aning, Obed Akwasi, et al.
Publicado: (2019) -
Be quiet and you'll keep young: does mTOR underlie p53 action in protecting against senescence by favoring quiescence?
por: Dulic, Vjekoslav
Publicado: (2011) -
The choice between p53-induced senescence and quiescence is
determined in part by the mTOR pathway
por: Korotchkina, Lioubov G., et al.
Publicado: (2010)